RX Share Price

Open 8.14 Change Price %
High 8.14 1 Day -0.01 -0.12
Low 8.14 1 Week 0.33 4.23
Close 8.14 1 Month 0.36 4.63
Volume 1250 1 Year 1.27 18.49
52 Week High 9.12
52 Week Low 6.88
RX Important Levels
Resistance 2 8.14
Resistance 1 8.14
Pivot 8.14
Support 1 8.14
Support 2 8.14
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
ICG 1.12 -1.75%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
BBI 0.41 -6.82%
BBI 0.41 -6.82%
More..
CVE Canada Top Gainers Stocks
SDR 0.02 100.00%
SDR 0.02 100.00%
SDR 0.02 100.00%
DDX 0.50 100.00%
WRP 0.02 100.00%
AVC 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
CZH 0.02 100.00%
CZH 0.02 100.00%
More..
CVE Canada Top Losers Stocks
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
GTC 0.02 -50.00%
GTC 0.02 -50.00%
SHM 0.14 -44.00%
SHM 0.14 -44.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Biosyent Inc (CVE: RX)

RX Technical Analysis 4
As on 23rd May 2017 RX Share Price closed @ 8.14 and we RECOMMEND Buy for LONG-TERM with Stoploss of 7.91 & Strong Buy for SHORT-TERM with Stoploss of 7.69 we also expect STOCK to react on Following IMPORTANT LEVELS.
RX Target for May
1st Target up-side 8.05
2nd Target up-side 8.23
3rd Target up-side 8.42
1st Target down-side 7.51
2nd Target down-side 7.33
3rd Target down-side 7.14
RX Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.biosyent.com
RX Address
RX
170 Attwell Drive
Suite 520
Toronto, ON M9W 5Z5
Canada
Phone: 905-206-0013
Fax: 905-206-1413
RX Latest News
Focusing the Lens On This Dividend Stock: BioSyent Inc. (TSXV:RX)   Geneva Journal   - 23rd May 17
A Look at Valuation For Shares of BioSyent Inc. (TSXV:RX)   Stock Talker   - 23rd May 17
Biosyent Inc. (RX) Analysts See $0.08 EPS; Bp Wealth Management Has Upped Its ...   NormanObserver.com   - 18th May 17
BRIEF-Biosyent extends in-license agreement for cathejell   Reuters   - 21st Apr 17
BioSyent Releases Results for Fourth Quarter and Full Year 2016   Marketwired (press release)   - 15th Mar 17
BioSyent Schedules Fourth Quarter 2016 Earnings Release for March 15, 2017   Marketwired (press release)   - 06th Mar 17
BioSyent Pharma Launches New Urgent Care Product   Marketwired (press release)   - 14th Nov 16
BioSyent: A High Growth Niche Pharma Company With Some Catalysts For ...   Seeking Alpha   - 17th Jun 15
BioSyent Pharma Announces the Canadian Launch of the First of 3 New Products ...   Marketwired (press release)   - 03rd Feb 15
8.15   MarketWatch   - 19th Apr 11
Interactive Technical Analysis Chart Biosyent Inc ( RX CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Biosyent Inc
RX Business Profile
BioSyent Inc., a life science company, engages in the marketing of pharmaceutical products in Canada. It is also involved in manufacturing and marketing non-chemical bio and health-friendly insecticides worldwide. The company markets FeraMAX 150, an oral hematinic for the prevention and treatment of iron deficiency anaemia; and FeraMAX Powder, an oral iron supplement. It also offers Cathejell Jelly 2% indicated for surface anesthesia and lubrication for various procedures, including male and female cystoscopies, catheterizations, and other endourethral operations; endoscopies, proctoscopies, and rectoscopies; and tracheal intubations, as well as used for the symptomatic treatment of pain in connection with cystitis and urethritis. In addition, BioSyent Inc. manufactures and markets Protect-It, a non-chemical, food-safe grain insecticide used as a preventative treatment against insect infestations in stored grains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006 to reflect its forward focus on the pharmaceutical market. BioSyent Inc. was incorporated in 1947 and is headquartered in Toronto, Canada.